Source: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: DIABETES MELLITUS, ANTAGONISTAS, RECEPTORES ADRENÉRGICOS, FREQUÊNCIA CARDÍACA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDOTTO, Glauco H. B. et al. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism. The Journal of Clinical Pharmacology, v. 57, n. 6, p. 760-769, 2017Tradução . . Disponível em: https://doi.org/10.1002/jcph.864. Acesso em: 13 nov. 2024.APA
Nardotto, G. H. B., Coelho, E. B., Paiva, C. E., & Lanchote, V. L. (2017). Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism. The Journal of Clinical Pharmacology, 57( 6), 760-769. doi:10.1002/jcph.864NLM
Nardotto GHB, Coelho EB, Paiva CE, Lanchote VL. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 760-769.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/jcph.864Vancouver
Nardotto GHB, Coelho EB, Paiva CE, Lanchote VL. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 760-769.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1002/jcph.864
